What is Zacks Research's Estimate for ACHC FY2024 Earnings?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Equities researchers at Zacks Research boosted their FY2024 earnings estimates for shares of Acadia Healthcare in a research note issued to investors on Wednesday, December 18th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings per share of $3.39 for the year, up from their previous forecast of $3.37. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare's Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.77 EPS and Q4 2025 earnings at $0.99 EPS.

Several other analysts have also commented on ACHC. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada reduced their price objective on Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a report on Monday, November 18th. StockNews.com upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday. Finally, KeyCorp initiated coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $75.44.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded down $0.40 during midday trading on Monday, reaching $37.50. The company had a trading volume of 2,655,637 shares, compared to its average volume of 1,069,152. The stock has a market cap of $3.48 billion, a P/E ratio of 12.30, a P/E/G ratio of 1.77 and a beta of 1.30. The company's 50 day moving average price is $43.80 and its 200 day moving average price is $60.73. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same period last year, the company posted $0.91 earnings per share. Acadia Healthcare's quarterly revenue was up 8.7% compared to the same quarter last year.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the business. GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after purchasing an additional 241 shares during the last quarter. Commonwealth Equity Services LLC increased its holdings in shares of Acadia Healthcare by 3.5% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company's stock worth $513,000 after buying an additional 257 shares during the last quarter. Atria Investments Inc raised its position in shares of Acadia Healthcare by 4.7% during the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company's stock valued at $434,000 after buying an additional 308 shares in the last quarter. KBC Group NV lifted its holdings in shares of Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company's stock worth $170,000 after acquiring an additional 338 shares during the last quarter. Finally, Tidal Investments LLC increased its stake in Acadia Healthcare by 7.9% in the third quarter. Tidal Investments LLC now owns 4,664 shares of the company's stock valued at $296,000 after acquiring an additional 340 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.